FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377826681> ?p ?o ?g. }

• W4377826681 abstract "Conventional drug-eluting stents achieve good safety and performance outcomes, but the stents permanently cage the vessel, leading to a non-plateauing rate of clinical events. The DynamX Bioadaptor is designed to reduce these long-term events through unique design features that permit restoring vessel function and physiology through the disengagement of uncaging elements after the resorption of a biodegradable polymer over six months. Promising initial results have been obtained in the DynamX mechanistic study, with excellent safety and effectiveness, positive arterial remodeling, improved vasomotion, compliance, and cyclic pulsatility. We now aim to confirm these findings randomizing the DynamX Bioadaptor against the Resolute Onyx stent.This multi-center, international, randomized single-blinded study is conducted in 34 sites across Europe, Japan, and New Zealand and is divided into the European/New Zealand cohort and the Japanese cohort (which includes an imaging subset). It is designed to randomly assign 444 patients (222 per region) in a 1:1 ratio to either the DynamX Bioadaptor or the Resolute Onyx stent. Furthermore, a pharmacokinetic substudy is conducted in 9 patients enrolled in Japan to assess the pharmacokinetics of sirolimus after implantation of the DynamX Bioadaptor. Study follow-up is scheduled at one, six, and 12 months, and annually thereafter for five years; imaging follow-up includes angiographic, intravascular ultrasound, and optical coherence tomography assessments at 12 months in a subset of patients. The primary endpoint is 12-month target lesion failure.This trial will provide valuable insights into the safety and efficacy of this novel bioadaptor when compared to a contemporary drug-eluting stent.The DynamX Sirolimus-Eluting Bioadaptor has unique design features aiming to reduce long-term events after percutaneous coronary intervention by permitting the restoration of vessel function through the freeing of uncaging elements. Promising initial results have been obtained in the DynamX mechanistic study. This trial aims to confirm these findings in a randomized setting. The European/ New Zealand and Japanese cohorts were designed to randomly assign 444 subjects in a 1:1 ratio to either the DynamX Bioadaptor or the Resolute Onyx stent. Furthermore, a pharmacokinetic substudy is conducted in 9 patients enrolled in Japan to assess the pharmacokinetics of sirolimus." @default.
• W4377826681 created "2023-05-24" @default.
• W4377826681 creator A5021162166 @default.
• W4377826681 creator A5043375132 @default.
• W4377826681 creator A5057368267 @default.
• W4377826681 creator A5079278619 @default.
• W4377826681 date "2023-05-01" @default.
• W4377826681 modified "2023-09-23" @default.
• W4377826681 title "DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCT" @default.
• W4377826681 cites W1986205344 @default.
• W4377826681 cites W2065463708 @default.
• W4377826681 cites W2066885533 @default.
• W4377826681 cites W2115183781 @default.
• W4377826681 cites W2252647110 @default.
• W4377826681 cites W2542709139 @default.
• W4377826681 cites W2582022641 @default.
• W4377826681 cites W2740021276 @default.
• W4377826681 cites W2808359328 @default.
• W4377826681 cites W3005080544 @default.
• W4377826681 cites W3008329648 @default.
• W4377826681 cites W3083989918 @default.
• W4377826681 cites W3203649536 @default.
• W4377826681 cites W4205653014 @default.
• W4377826681 cites W4297176868 @default.
• W4377826681 doi "https://doi.org/10.1016/j.carrev.2023.05.010" @default.
• W4377826681 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37479544" @default.
• W4377826681 hasPublicationYear "2023" @default.
• W4377826681 type Work @default.
• W4377826681 citedByCount "0" @default.
• W4377826681 crossrefType "journal-article" @default.
• W4377826681 hasAuthorship W4377826681A5021162166 @default.
• W4377826681 hasAuthorship W4377826681A5043375132 @default.
• W4377826681 hasAuthorship W4377826681A5057368267 @default.
• W4377826681 hasAuthorship W4377826681A5079278619 @default.
• W4377826681 hasConcept C126322002 @default.
• W4377826681 hasConcept C141071460 @default.
• W4377826681 hasConcept C164705383 @default.
• W4377826681 hasConcept C168563851 @default.
• W4377826681 hasConcept C203092338 @default.
• W4377826681 hasConcept C2776931568 @default.
• W4377826681 hasConcept C2777546689 @default.
• W4377826681 hasConcept C2778283817 @default.
• W4377826681 hasConcept C2778583881 @default.
• W4377826681 hasConcept C2780400711 @default.
• W4377826681 hasConcept C2780797203 @default.
• W4377826681 hasConcept C2781464078 @default.
• W4377826681 hasConcept C500558357 @default.
• W4377826681 hasConcept C71924100 @default.
• W4377826681 hasConcept C72563966 @default.
• W4377826681 hasConceptScore W4377826681C126322002 @default.
• W4377826681 hasConceptScore W4377826681C141071460 @default.
• W4377826681 hasConceptScore W4377826681C164705383 @default.
• W4377826681 hasConceptScore W4377826681C168563851 @default.
• W4377826681 hasConceptScore W4377826681C203092338 @default.
• W4377826681 hasConceptScore W4377826681C2776931568 @default.
• W4377826681 hasConceptScore W4377826681C2777546689 @default.
• W4377826681 hasConceptScore W4377826681C2778283817 @default.
• W4377826681 hasConceptScore W4377826681C2778583881 @default.
• W4377826681 hasConceptScore W4377826681C2780400711 @default.
• W4377826681 hasConceptScore W4377826681C2780797203 @default.
• W4377826681 hasConceptScore W4377826681C2781464078 @default.
• W4377826681 hasConceptScore W4377826681C500558357 @default.
• W4377826681 hasConceptScore W4377826681C71924100 @default.
• W4377826681 hasConceptScore W4377826681C72563966 @default.
• W4377826681 hasLocation W43778266811 @default.
• W4377826681 hasLocation W43778266812 @default.
• W4377826681 hasOpenAccess W4377826681 @default.
• W4377826681 hasPrimaryLocation W43778266811 @default.
• W4377826681 hasRelatedWork W1993019255 @default.
• W4377826681 hasRelatedWork W2101992832 @default.
• W4377826681 hasRelatedWork W2141196495 @default.
• W4377826681 hasRelatedWork W2144552468 @default.
• W4377826681 hasRelatedWork W2160631086 @default.
• W4377826681 hasRelatedWork W2414576070 @default.
• W4377826681 hasRelatedWork W2482987107 @default.
• W4377826681 hasRelatedWork W2770371584 @default.
• W4377826681 hasRelatedWork W3014766400 @default.
• W4377826681 hasRelatedWork W3107484367 @default.
• W4377826681 isParatext "false" @default.
• W4377826681 isRetracted "false" @default.
• W4377826681 workType "article" @default.